Vandria Reports First Human Data for Mitophagy-Based Alzheimer’s Drug VNA-318

Vandria Reports First Human Data for Mitophagy-Based Alzheimer’s Drug VNA-318

Vandria has announced the first-in-human data for its A […] The post Vandria Reports First Human Data for Mitophagy-Based Alzheimer’s Drug VNA-318 first appeared on GeneOnline News. The post Vandria Reports First Human Data for Mitophagy-Based Alzheimer’s Drug VNA-318 appeared first on GeneOnline News.

Vandria reports VNA-318’s first-in-human data in Alzheimer’s

Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's to reach the clinic. The post Vandria reports VNA-318’s first-in-human data in Alzheimer’s appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and link…